MP47-06 IMPACT OF VARIANT HISTOLOGY ON RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR UROTHELIAL BLADDER CANCER

Urothelial Bladder ◽

Variant Histology ◽

Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2018.09.008 ◽

2019 ◽

Vol 37 (1) ◽

pp. 1-11 ◽

Cited By ~ 2

Author(s):

Soroush T. Bazargani ◽

Thomas G. Clifford ◽

Hooman Djaladat ◽

Anne K. Schuckman ◽

Kevin Wayne ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Marker ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology

Future Oncology ◽

10.2217/fon-2016-0056 ◽

2016 ◽

Vol 12 (15) ◽

pp. 1795-1804 ◽

Cited By ~ 2

Author(s):

Hristos Z Kaimakliotis ◽

M Francesca Monn ◽

Jane S Cho ◽

Jose A Pedrosa ◽

Noah M Hahn ◽

...

Keyword(s):

Bladder Cancer ◽

Urothelial Bladder ◽

405 Urothelial bladder cancer: Bcl-2 is upregulated in lymph node metastases and a marker of unfavourable response to neoadjuvant chemotherapy

European Urology Supplements ◽

10.1016/s1569-9056(14)60400-0 ◽

2014 ◽

Vol 13 (1) ◽

pp. e405

Author(s):

V. Skuginna ◽

B. Kiss ◽

A. Fleischmann ◽

G.N. Thalmann ◽

R. Seiler

Keyword(s):

Bladder Cancer ◽

Lymph Node ◽

Lymph Node Metastases ◽

Urothelial Bladder ◽

Node Metastases ◽

Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.01.024 ◽

2017 ◽

Vol 15 (4) ◽

pp. e697-e706 ◽

Cited By ~ 9

Author(s):

Oscar Buisan ◽

Anna Orsola ◽

Mario Oliveira ◽

Roberto Martinez ◽

Olatz Etxaniz ◽

...

Keyword(s):

Bladder Cancer ◽

Squamous Cell ◽

Perioperative Management ◽

Neutrophil To Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Urothelial Bladder ◽

MP06-05 PRECYSTECTOMY EPITHELIAL TUMOR MARKER RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND ITS EFFECT ON ONCOLOGICAL OUTCOMES IN UROTHELIAL BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.2166 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Soroush T Bazargani ◽

Thomas G. Clifford ◽

Hooman Djaladat ◽

Anne Schuckman ◽

Sarmad Sadeghi ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Marker ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2020.06.004 ◽

2020 ◽

Author(s):

Ryan W. Speir ◽

Marcelo Panizzutti Barboza ◽

Adam Calaway ◽

Timothy A. Masterson ◽

Clint Cary ◽

...

Keyword(s):

Bladder Cancer ◽

Urothelial Bladder ◽

Pathologic down-staging following standard (SD) MVAC (methotrexate-vinblastine-doxorubicine-cisplatin) or dose-dense MVAC (DD) neoadjuvant chemotherapy (NC) for muscle-invasive urothelial bladder cancer (UC): A retrospective multicenter cohort of the French Genitourinary Tumor Group (GETUG/AFU).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4550 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4550-4550 ◽

Cited By ~ 1

Author(s):

Damien Pouessel ◽

Sylvie Chevret ◽

Emmanuelle Bompas ◽

Laurys Boudin ◽

Charlotte Joly ◽

...

Keyword(s):

Bladder Cancer ◽

Multicenter Cohort ◽

Tumor Group ◽

Urothelial Bladder ◽

Muscle Invasive ◽

Dose Dense

MP55-07 SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN VARIANT HISTOLOGY UROTHELIAL BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2014.02.1555 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

M Francesca Monn ◽

Hristos Z. Kaimakliotis ◽

Jose A. Pedrosa ◽

K Clint Cary ◽

Paul T. Gellhaus ◽

...

Keyword(s):

Bladder Cancer ◽

Lymph Node ◽

Lymph Node Involvement ◽

Node Involvement ◽

Urothelial Bladder ◽

650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy

European Urology Supplements ◽

10.1016/s1569-9056(15)60643-1 ◽

2015 ◽

Vol 14 (2) ◽

pp. e650-e650a

Author(s):

K. Zargar-Shoshtari ◽

H. Zargar ◽

A.S. Fairey ◽

L.S. Mertens ◽

C.P. Dinney ◽

...

Keyword(s):

Bladder Cancer ◽

Radical Cystectomy ◽

Institutional Analysis ◽

Survival Outcomes ◽

Node Positive ◽

Urothelial Bladder ◽

Clinically Node Positive

The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?

BJU International ◽

10.1111/bju.12877 ◽

2015 ◽

Vol 116 (2) ◽

pp. 236-240 ◽

Cited By ~ 7

Author(s):

M. Francesca Monn ◽

Hristos Z. Kaimakliotis ◽

K. Clint Cary ◽

Richard Bihrle ◽

Jose A. Pedrosa ◽

...

Keyword(s):

Bladder Cancer ◽

Clinical Entity ◽

Distinct Clinical Entity ◽

Urothelial Bladder ◽